Health Effects Following Use of Lead Free Ammunition Used With HK416
This study is ongoing, but not recruiting participants.
Sponsor:
Oslo University Hospital
Collaborator:
Norwegian Defence Research Establishment
Information provided by (Responsible Party):
Svein Grahnstedt, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01477645
First received: November 18, 2011
Last updated: September 11, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether use of lead free ammunitions cause more respiratory problems than use of lead containing ammunitions.
| Condition |
|---|
|
Lung Function Tests Markers of Inflammation |
| Study Type: | Observational |
| Study Design: | Observational Model: Ecologic or Community Time Perspective: Prospective |
| Official Title: | In Norwegian: Helseffekter av Stoff Som Avgis Ved Skyting Med HK416 |
Further study details as provided by Oslo University Hospital:
Biospecimen Retention: Samples Without DNA
Sputum and serum
| Estimated Enrollment: | 60 |
| Study Start Date: | November 2011 |
| Estimated Study Completion Date: | December 2012 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Leaded ammunition |
| Non-leaded ammunition |
| Modified non-leaded ammunition |
Eligibility| Ages Eligible for Study: | 20 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Voluntary army soldiers
Criteria
Inclusion Criteria:
- healthy volunteers
Exclusion Criteria:
- active respiratory disease
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01477645
Locations
| Norway | |
| Norwegian Defence Research Establishment | |
| Kjeller, Akershus, Norway, N-2007 | |
Sponsors and Collaborators
Oslo University Hospital
Norwegian Defence Research Establishment
Investigators
| Study Director: | Kjetil Longva, PhD | Norwegian Defence Reasearch Establishment |
| Principal Investigator: | Anne-Katrine Borander, MD | Oslo University Hospital |
| Principal Investigator: | Øyvind Albert Voie, PhD | Norwegian Research Defence Establishment |
| Study Director: | Johny S Kongerud, MD PhD | Oslo University Hospital |
| Principal Investigator: | Liv Ingunn Bjoner Sikkeland, PhD | Oslo University Hospital |
More Information
No publications provided
| Responsible Party: | Svein Grahnstedt, Senior Consultant MD PhD, Oslo University Hospital |
| ClinicalTrials.gov Identifier: | NCT01477645 History of Changes |
| Other Study ID Numbers: | 2011/1335 |
| Study First Received: | November 18, 2011 |
| Last Updated: | September 11, 2012 |
| Health Authority: | Norway: Ethics Committee |
Additional relevant MeSH terms:
|
Inflammation Pathologic Processes |
ClinicalTrials.gov processed this record on May 21, 2013